Overview

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fasting Conditions in Healthy Volunteers

Status:
Completed
Trial end date:
2023-10-06
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to evaluate the pharmacokinetics and the safety after administration of "BR1015" and co-administration of "BR1015-1" and "BR1015-2" under fasting conditions in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd